# Niacin and Endothelial Function in Early CKD

> **NCT00852969** · PHASE4 · COMPLETED · sponsor: **Tufts Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Niacin
- **DRUG:** Active Placebo

## Key facts

- **NCT ID:** NCT00852969
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852969, "Niacin and Endothelial Function in Early CKD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00852969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*